Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lung cancer
Phenotype C0015230|rash
Sentences 5
PubMedID- 25670908 Changes in sebum levels and the development of acneiform rash in patients with non-small cell lung cancer after treatment with egfr inhibitors.
PubMedID- 23207012 Reduced cyp2d6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer.
PubMedID- 21169060 First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the flex phase 3 study.
PubMedID- 22337328 [prognostic relevance of body mass index and rash for patients with metastatic non-small-cell lung cancer under therapy with erlotinib].
PubMedID- 24278074 The aim of this work was to present of a case of a lung cancer patient with acneiform rash that appeared during treatment with erlotinib (tarceva®).

Page: 1